Desano (Shanghai) Overview
- Year Founded
-
2000
- Status
-
Private
- Employees
-
115
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
7
- Investments
-
3
Desano (Shanghai) General Information
Description
Manufacturer and developer of pharmaceutical products, preparations, and intermediates designed to meet growing demand of global treatment of HIV and malaria. The company's products include anti-viral and anti-malarial drugs as well as finished antibiotics, anti-retrovirals and cardiovascular drugs, enabling doctors across the world to treat debilitating diseases.
Contact Information
Website
www.desano.comCorporate Office
- No.1479 Zhangheng Road
- China (Shanghai) Pilot Free Trade Zone
- Shanghai, 201203
- China
Corporate Office
- No.1479 Zhangheng Road
- China (Shanghai) Pilot Free Trade Zone
- Shanghai, 201203
- China
Desano (Shanghai) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Desano (Shanghai) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Desano (Shanghai) Patents
Desano (Shanghai) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025162491-A1 | Method for preparing finerenone and method for preparing finerenone intermediate | Pending | 30-Jan-2024 | ||
| WO-2022100395-A1 | Baloxavir marboxil crystal form d and preparation method therefor | Inactive | 12-Nov-2020 | ||
| WO-2021233434-A1 | New crystal form of bictegravir sodium and preparation method therefor | Inactive | 22-May-2020 | ||
| AU-2020414895-A1 | Method for preparing isavuconazonium sulfate | Active | 25-Dec-2019 | ||
| AU-2020414895-B2 | Method for preparing isavuconazonium sulfate | Active | 25-Dec-2019 | C07D417/14 |
Desano (Shanghai) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Desano (Shanghai) Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Desano (Shanghai) Investments (3)
Desano (Shanghai)’s most recent deal was a Later Stage VC with Kangfude Pharmaceutical for . The deal was made on 24-Jul-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Kangfude Pharmaceutical | 24-Jul-2024 | Later Stage VC | Drug Discovery | ||
| Genuine Biotech | 12-Apr-2022 | Later Stage VC | Pharmaceuticals | ||
| KYF (Pharmaceuticals) | 27-Jan-2022 | Secondary Transaction - Private | Pharmaceuticals |
Desano (Shanghai) FAQs
-
When was Desano (Shanghai) founded?
Desano (Shanghai) was founded in 2000.
-
Where is Desano (Shanghai) headquartered?
Desano (Shanghai) is headquartered in Shanghai, China.
-
What is the size of Desano (Shanghai)?
Desano (Shanghai) has 115 total employees.
-
What industry is Desano (Shanghai) in?
Desano (Shanghai)’s primary industry is Pharmaceuticals.
-
Is Desano (Shanghai) a private or public company?
Desano (Shanghai) is a Private company.
-
What is Desano (Shanghai)’s current revenue?
The current revenue for Desano (Shanghai) is .
-
Who are Desano (Shanghai)’s investors?
CCB Equity Investment Management, CICC Jia Cheng Investment Management Company, Healthib Capital, Shanghai CICC Capital Investment, and Xiamen Torch Group Venture Capital are 5 of 21 investors who have invested in Desano (Shanghai).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
